ホルター心電図の市場：製品（有線ホルター心電図、無線ホルター心電図、ソフトウェア）、リードタイプ（パッチタイプ1リード、3リード、6リード、12リード）、エンドユーザー（病院および専門クリニック、外来手術センター）、地域別 - 2027年までの世界予測

Holter ECG Market by Product (Wired Holter ECG, Wireless Holter ECG, Software), Lead Type (Patch Type 1-Lead, 3-Lead, 6-Lead, 12-Lead), EndUser (Hospitals and Specialty Clinics, Ambulatory Surgical Centers), & Region - Global Forecast to 2027

ホルターECGの世界市場は、予測期間中に6.1%のCAGRで、2022年の4億1600万米ドルから2027年には5億5800万米ドルに達すると予測されます。人口の高齢化、心血管疾患（CVD）有病率の上昇、早期かつ継続的な診断の必... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年4月26日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	182	171	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

ホルターECGの世界市場は、予測期間中に6.1%のCAGRで、2022年の4億1600万米ドルから2027年には5億5800万米ドルに達すると予測されます。人口の高齢化、心血管疾患（CVD）有病率の上昇、早期かつ継続的な診断の必要性の認識、ウェアラブルデバイスの技術開発などが、ホルターECG市場の拡大に寄与しています。
"予測期間中、有線ホルターECGモニター部門が最も高い市場シェアを占める"
ホルター心電図市場は、製品別に有線ホルター心電図モニター、無線ホルター心電図モニター、ソフトウェアに分類されます。有線ホルターECGモニター分野は、予測期間中に高い市場シェアを占めると予想されます。この市場の成長は、主にCVDの有病率の増加とその治療に関連するコストを最小限に抑える必要性、および心臓活動の診断において有線ホルターECGデバイスが提供する高い精度と正確さによってもたらされます。
「予測期間中、12リードホルターモニターが最も高いCAGRを占める"
リードタイプに基づき、ホルターECG市場はパッチタイプ1リード、3リード、6リード、12リード、その他のリードタイプ（4リード、5リード、7リードのホルターECGモニターなど）に区分されます。2021年には、12リードが市場を支配し、3リードが最も高い成長率を観測しました。このセグメントの大きなシェアは、さまざまな心臓病診断および治療アプリケーションで12リードホルターモニターが広く使用されていることに起因すると考えられます。
"予測期間中、北米セグメントが最も高い市場シェアを占めた"
地域区分に基づいて、ホルターECG市場は、北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東アフリカに分けられます。北米は最大のシェアを占めており、ホルターECG市場を支配すると予想されています。この地域市場の成長は、心血管疾患の有病率の増加、高齢化人口の増加、リモートモニタリングの需要の高まりに支えられています。
供給側の一次インタビューの内訳（企業タイプ別、呼称別、地域別）：
- 企業タイプ別ティア1（40％）、ティア2（30％）、ティア3（30％）：ティア1（40％）、ティア2（30％）、ティア3（30％）。
- 役職別Cレベル（27％）、ディレクターレベル（18％）、その他（55％）。
- 地域別北米(51%)、アジア太平洋(18%)、欧州(21%)、中南米(6%)、中東・アフリカ(4%)。
主な企業は、GE HealthCare（米国）、Koninklijke Philips N.V.（オランダ）、日本光電工業株式会社（日本）、OSI Systems, Inc（米国）、Hill-Rom Holdings, Inc（Baxter International Inc）（米国）、Mindray Medical International Limited（中国）、SCHILLER AG（スイス）、Bittium Corporation（フィンランド）、福田電子工業株式会社、株式会社エフ・エム・シー（日本）。(日本)、BPL Medical Technologies Pvt.Ltd. (インド)、Meditech Equipment, Inc.(インド)、Meditech Equipment Co.Ltd.（日本）、BPL Medical Technologies Pvt.(中国）、Midmark Corporation（米国）、AliveCor, Inc.（米国）、VitalConnect（米国）、iRhythm Technologies, Inc.（米国）、Borsam Biomedical Instruments Co.(中国)、Nasiff Associates, Inc.（米国）、Nasan Medical Electronics Pvt.Ltd. （インド）、VectraConnect, Inc.(インド)、VectraCor(米国)、ScottCare Corporation(米国)、Biomedical Instruments Co.Ltd.（中国）、EB Neuro Co.(中国)、EB Neuro S.p.A.(イタリア)、Viatom Technology Co.(中国)、Cardiac Insight, Inc.（米国）、LifeSignals, Inc.（米国）。

調査対象
この調査レポートは、ホルターECG市場を製品別、リードタイプ別、エンドユーザー別、地域別に分類しています。ホルターECG市場の成長に影響を与える促進要因、阻害要因、課題、機会などの主要要因に関する詳細情報を網羅しています。主要な業界プレイヤーを詳細に分析し、事業概要、ソリューション、サービス、主要戦略、契約、パートナーシップ、協定、新製品・サービスの発表、M&A、ホルターECG市場に関連する最新動向に関する洞察を提供しています。ホルターECG市場のエコシステムにおける今後の新興企業の競争力分析も本レポートで取り上げています。

レポートを購入する主な利点
本レポートは、ホルターECG市場全体とサブセグメントの収益数値の最も近い近似値に関する情報を提供し、本市場のマーケットリーダー/新規参入者の助けとなります。本レポートは、利害関係者が競争環境を理解し、より多くの洞察を得ることで、自社のビジネスをより良く位置づけ、適切な市場参入戦略を計画するのに役立ちます。また、本レポートは、関係者が市場の鼓動を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、および機会に関する情報を提供します。
本レポートは、以下のポイントに関する洞察を提供します：
- ホルターECG市場の成長に影響を与える主要なドライバー、阻害要因、機会、課題の分析
- 製品開発/イノベーション：ホルター心電計市場における今後の技術、研究開発活動、新製品・サービス開始に関する詳細なインサイトを掲載。
- 市場開発：有利な市場に関する包括的な情報 - 本レポートでは、さまざまな地域のホルター心電計市場を分析しています。
- 市場の多様化：ホルターECG市場における新製品・サービス、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。
- 競合他社の評価：ホルターECG市場戦略におけるGE HealthCare社（米国）、Koninklijke Philips N.V.（オランダ）、日本光電工業株式会社（日本）、OSI Systems, Inc（米国）、Hill-Rom Holdings, Inc（Baxter International Inc）（米国）などの主要企業の市場ランキング、成長戦略、サービス提供状況を詳細に評価します。

ページTOPに戻る

1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.2.1 INCLUSIONS AND EXCLUSIONS 25
1.3 MARKETS COVERED 26
1.3.1 HOLTER ECG MARKET SEGMENTATION 26
1.3.2 GEOGRAPHIC SCOPE 26
1.3.3 YEARS CONSIDERED 27
1.4 CURRENCY CONSIDERED 27
1.5 STUDY LIMITATIONS 27
1.6 STAKEHOLDERS 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
FIGURE 1 HOLTER ECG MARKET: RESEARCH DESIGN METHODOLOGY 29
2.1.1 SECONDARY DATA 30
2.1.1.1 Key data from secondary sources 30
2.1.2 PRIMARY DATA 31
2.1.2.1 Primary sources 32
2.1.2.2 Key data from primary sources 32
2.1.2.3 Key industry insights 33
2.1.2.4 Breakdown of primary interviews 33
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 33
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 34
2.2 MARKET SIZE ESTIMATION 34
2.2.1 BOTTOM-UP APPROACH 35
2.2.1.1 Approach 1: Company revenue estimation approach 35
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 35
2.2.1.2 Approach 2: Presentations of companies and primary interviews 35
2.2.1.3 Growth forecast 36
2.2.1.4 CAGR projections 36
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 36
2.2.2 TOP-DOWN APPROACH 37
FIGURE 6 HOLTER ECG MARKET: TOP-DOWN APPROACH 37
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 38
FIGURE 7 DATA TRIANGULATION METHODOLOGY 38

2.4 MARKET SHARE 39
2.5 STUDY ASSUMPTIONS 39
2.6 RISK ASSESSMENT 39
2.6.1 RISK ASSESSMENT: HOLTER ECG MARKET 39
2.7 RECESSION IMPACT 40
3 EXECUTIVE SUMMARY 41
FIGURE 8 HOLTER ECG MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 41
FIGURE 9 HOLTER ECG MARKET, BY LEAD TYPE, 2022 VS. 2027 (USD MILLION) 42
FIGURE 10 HOLTER ECG MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 42
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF HOLTER ECG MARKET, 2022 VS. 2027 (USD MILLION) 43
4 PREMIUM INSIGHTS 44
4.1 HOLTER ECG MARKET OVERVIEW 44
FIGURE 12 RISING INCIDENCE OF CARDIOVASCULAR DISEASE TO DRIVE MARKET GROWTH 44
4.2 HOLTER ECG MARKET SHARE, BY PRODUCT, 2022 VS. 2027 45
FIGURE 13 WIRED HOLTER ECG MONITORS SEGMENT TO HOLD LARGEST SHARE OF MARKET IN 2027 45
4.3 HOLTER ECG MARKET SHARE, BY LEAD TYPE, 2022 VS. 2027 45
FIGURE 14 12-LEAD HOLTER MONITORS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2027 45
4.4 HOLTER ECG MARKET SHARE, BY END USER, 2022 VS. 2027 46
FIGURE 15 HOSPITALS AND SPECIALTY CLINICS SEGMENT TO DOMINATE MARKET IN 2027 46
4.5 HOLTER ECG MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 46
FIGURE 16 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 46
5 MARKET OVERVIEW 47
5.1 INTRODUCTION 47
5.2 MARKET DYNAMICS 47
FIGURE 17 HOLTER ECG MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 47
5.2.1 DRIVERS 48
5.2.1.1 Rising geriatric population 48
FIGURE 18 GROWTH IN AGING POPULATION, BY COUNTRY, 2015 VS. 2030 48
5.2.1.2 Increasing prevalence of cardiovascular disease 49
5.2.1.3 Technological advancements in wireless monitoring and wearable devices 49
5.2.1.4 Increasing investments, funds, and grants for research on cardiac monitoring 50

5.2.2 RESTRAINTS 51
5.2.2.1 Frequent product recalls 51
TABLE 1 KEY PRODUCT RECALLS 51
5.2.3 OPPORTUNITIES 51
5.2.3.1 Untapped emerging markets 51
5.2.4 CHALLENGES 52
5.2.4.1 Stringent regulatory requirements delaying approval of cardiac devices 52
5.2.4.2 Dearth of skilled professionals with expertise in handling cardiac monitoring devices 52
5.3 PRICING ANALYSIS 53
TABLE 2 AVERAGE SELLING PRICE OF HOLTER ECG MONITORING PRODUCTS (2022) 53
5.4 PATENT ANALYSIS 54
FIGURE 19 PATENT ANALYSIS FOR HOLTER ECG MARKET 54
5.4.1 LIST OF KEY PATENTS 55
5.5 VALUE CHAIN ANALYSIS 56
FIGURE 20 VALUE CHAIN ANALYSIS OF HOLTER ECG MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 56
5.6 SUPPLY CHAIN ANALYSIS 57
FIGURE 21 HOLTER ECG MARKET: SUPPLY CHAIN ANALYSIS 57
5.7 ECOSYSTEM ANALYSIS 58
FIGURE 22 HOLTER ECG MARKET: ECOSYSTEM ANALYSIS 58
5.7.1 HOLTER ECG MARKET: ROLE IN ECOSYSTEM 58
5.8 PORTER’S FIVE FORCES ANALYSIS 59
TABLE 3 HOLTER ECG MARKET: PORTER’S FIVE FORCES ANALYSIS 59
5.8.1 THREAT OF NEW ENTRANTS 59
5.8.2 THREAT OF SUBSTITUTES 59
5.8.3 BARGAINING POWER OF BUYERS 59
5.8.4 BARGAINING POWER OF SUPPLIERS 59
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 60
5.9 REGULATORY ANALYSIS 60
TABLE 4 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 60
TABLE 5 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 60
TABLE 6 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 61
TABLE 7 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 61
TABLE 8 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 61

5.9.1 NORTH AMERICA 62
5.9.1.1 US 62
5.9.1.2 Canada 62
5.9.2 EUROPE 62
5.9.3 ASIA PACIFIC 62
5.9.3.1 China 62
5.9.3.2 Japan 63
5.9.3.3 India 63
5.9.4 LATIN AMERICA 63
5.9.4.1 Brazil 63
5.9.4.2 Mexico 63
5.9.5 MIDDLE EAST 64
5.9.6 AFRICA 64
5.10 TRADE ANALYSIS 65
5.10.1 TRADE ANALYSIS FOR HOLTER ECG PRODUCTS 65
TABLE 9 IMPORT DATA FOR HOLTER ECG PRODUCTS, BY COUNTRY, 2018–2022 (USD MILLION) 65
TABLE 10 EXPORT DATA FOR HOLTER ECG PRODUCTS, BY COUNTRY, 2018–2022 (USD MILLION) 65
5.11 PESTLE ANALYSIS 66
5.12 TECHNOLOGY ANALYSIS 66
5.13 KEY CONFERENCES AND EVENTS, 2023–2024 67
TABLE 11 HOLTER ECG MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 67
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 68
5.14.1 REVENUE SHIFT AND REVENUE POCKETS FOR HOLTER ECG MONITOR MANUFACTURERS 68
FIGURE 23 REVENUE SHIFT IN HOLTER ECG MARKET 68
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 69
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 69
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOLTER ECG PRODUCTS 69
TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOLTER ECG PRODUCTS 69
5.15.2 BUYING CRITERIA 70
FIGURE 25 KEY BUYING CRITERIA FOR HOLTER ECG PRODUCTS 70
TABLE 13 KEY BUYING CRITERIA FOR HOLTER ECG PRODUCTS 70
5.16 CASE STUDIES 70
5.16.1 CASE STUDY 1 70
5.16.2 CASE STUDY 2 71

6 HOLTER ECG MARKET, BY PRODUCT 72
6.1 INTRODUCTION 73
TABLE 14 HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 73
6.2 WIRED HOLTER ECG MONITORS 73
6.2.1 GROWING CVD PREVALENCE AND NEED FOR CONTINUOUS MONITORING TO FUEL GROWTH 73
TABLE 15 INDICATIVE LIST OF WIRED HOLTER ECG MONITORS 74
TABLE 16 WIRED HOLTER ECG MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION) 74
6.3 WIRELESS HOLTER ECG MONITORS 74
6.3.1 INCREASING PREFERENCE FOR COMFORTABLE CARDIAC ACTIVITY MONITORING TO DRIVE GROWTH 74
TABLE 17 INDICATIVE LIST OF WIRELESS HOLTER ECG MONITORS 75
TABLE 18 WIRELESS HOLTER ECG MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION) 75
6.4 SOFTWARE 75
6.4.1 HOLTER ECG SOFTWARE HELPS PROVIDE CLINICIANS WITH QUICK INSIGHTS AND PROTECTED PATIENT DATA 75
TABLE 19 HOLTER ECG SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION) 76
7 HOLTER ECG MARKET, BY LEAD TYPE 77
7.1 INTRODUCTION 78
TABLE 20 HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 78
7.2 PATCH TYPE 1-LEAD HOLTER MONITORS 78
7.2.1 EASE OF USE FOR DIAGNOSIS AND QUICK RESULTS TO PROPEL MARKET GROWTH 78
TABLE 21 PATCH TYPE 1-LEAD HOLTER MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION) 79
7.3 3-LEAD HOLTER MONITORS 79
7.3.1 3-LEAD HOLTER MONITORS PERFORM MULTIPLE DIAGNOSTIC TESTS SIMULTANEOUSLY 79
TABLE 22 KEY PRODUCTS IN 3-LEAD HOLTER MONITORS MARKET 79
TABLE 23 3-LEAD HOLTER MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION) 80
7.4 6-LEAD HOLTER MONITORS 80
7.4.1 WIDE USE OF 6-LEAD HOLTER MONITORS FOR REMOTE PATIENT MONITORING TO DRIVE GROWTH 80
TABLE 24 KEY PRODUCTS IN 6-LEAD HOLTER MONITORS MARKET 80
TABLE 25 6-LEAD HOLTER MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION) 81
7.5 12-LEAD HOLTER MONITORS 81
7.5.1 WIDE USE IN PRE-HOSPITAL AND CLINIC SETTINGS TO DRIVE GROWTH 81
TABLE 26 KEY PRODUCTS IN 12-LEAD HOLTER MONITORS MARKET 81
TABLE 27 12-LEAD HOLTER MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION) 82
7.6 OTHER LEAD TYPES 82
TABLE 28 OTHER LEAD TYPE HOLTER MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION) 82
8 HOLTER ECG MARKET, BY END USER 83
8.1 INTRODUCTION 84
TABLE 29 HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 84
8.2 HOSPITALS AND SPECIALTY CLINICS 84
8.2.1 INCREASING NUMBER OF CARDIAC CENTERS TO SUPPORT GROWTH 84
TABLE 30 HOLTER ECG MARKET FOR HOSPITALS AND SPECIALTY CLINICS, BY REGION, 2020–2027 (USD MILLION) 85
8.3 AMBULATORY SURGICAL CENTERS 85
8.3.1 LOW-COST PROCEDURES TO DRIVE MARKET GROWTH 85
TABLE 31 HOLTER ECG MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020–2027 (USD MILLION) 86
8.4 OTHER END USERS 86
TABLE 32 HOLTER ECG MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION) 87
9 HOLTER ECG MARKET, BY REGION 88
9.1 INTRODUCTION 89
TABLE 33 HOLTER ECG MARKET, BY REGION, 2020–2027 (USD MILLION) 89
9.2 NORTH AMERICA 89
FIGURE 26 NORTH AMERICA: HOLTER ECG MARKET SNAPSHOT 90
TABLE 34 NORTH AMERICA: HOLTER ECG MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 90
TABLE 35 NORTH AMERICA: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 91
TABLE 36 NORTH AMERICA: HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 91
TABLE 37 NORTH AMERICA: HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 91
9.2.1 RECESSION IMPACT 92
9.2.2 US 92
9.2.2.1 Rising prevalence of heart diseases to drive growth 92
TABLE 38 US: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 92
TABLE 39 US: HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 93
TABLE 40 US: HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 93
9.2.3 CANADA 93
9.2.3.1 Increasing geriatric patient pool to support growth 93
TABLE 41 CANADA: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 94
TABLE 42 CANADA: HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 94
TABLE 43 CANADA: HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 95

9.3 EUROPE 95
TABLE 44 EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY (% OF GDP) 96
TABLE 45 EUROPE: HOLTER ECG MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 96
TABLE 46 EUROPE: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 97
TABLE 47 EUROPE: HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 97
TABLE 48 EUROPE: HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 97
9.3.1 RECESSION IMPACT 98
9.3.2 GERMANY 98
9.3.2.1 Increasing healthcare expenditure to fuel market growth 98
TABLE 49 GERMANY: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 99
TABLE 50 GERMANY: HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 99
TABLE 51 GERMANY: HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 99
9.3.3 UK 100
9.3.3.1 Rising demand for home-based cardiac monitoring devices to support market growth 100
TABLE 52 UK: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 100
TABLE 53 UK: HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 101
TABLE 54 UK: HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 101
9.3.4 FRANCE 101
9.3.4.1 Increasing risk of cardiovascular disease to propel growth 101
TABLE 55 FRANCE: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 102
TABLE 56 FRANCE: HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 102
TABLE 57 FRANCE: HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 103
9.3.5 ITALY 103
9.3.5.1 High prevalence of cardiovascular disease to drive growth 103
TABLE 58 ITALY: NUMBER OF ELDERLY CITIZENS WITH ATRIAL FIBRILLATION (THOUSAND) 104
TABLE 59 ITALY: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 104
TABLE 60 ITALY: HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 105
TABLE 61 ITALY: HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 105
9.3.5.2 Rising geriatric population to propel growth 105
TABLE 62 SPAIN: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 106
TABLE 63 SPAIN: HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 106
TABLE 64 SPAIN: HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 107
9.3.6 NETHERLANDS 107
9.3.6.1 Increasing prevalence of coronary heart disease to drive growth 107
TABLE 65 NETHERLANDS: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 108
TABLE 66 NETHERLANDS: HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 108
TABLE 67 NETHERLANDS: HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 108
9.3.7 REST OF EUROPE 109
TABLE 68 PERCENTAGE OF POPULATION AGED 60 OR OVER, 2017 VS. 2050 109
TABLE 69 REST OF EUROPE: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 109
TABLE 70 REST OF EUROPE: HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 110
TABLE 71 REST OF EUROPE: HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 110
9.4 ASIA PACIFIC 110
FIGURE 27 ASIA PACIFIC: HOLTER ECG MARKET SNAPSHOT 112
TABLE 72 ASIA PACIFIC: HOLTER ECG MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 113
TABLE 73 ASIA PACIFIC: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 113
TABLE 74 ASIA PACIFIC: HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 114
TABLE 75 ASIA PACIFIC: HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 114
9.4.1 RECESSION IMPACT 114
9.4.2 CHINA 115
9.4.2.1 Growing public access to modern healthcare to support growth 115
TABLE 76 CHINA: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 115
TABLE 77 CHINA: HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 116
TABLE 78 CHINA: HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 116
9.4.3 JAPAN 116
9.4.3.1 Favorable regulatory framework to drive growth 116
TABLE 79 JAPAN: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 117
TABLE 80 JAPAN: HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 117
TABLE 81 JAPAN: HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 118
9.4.4 INDIA 118
9.4.4.1 Increasing investment in healthcare system to drive market 118
TABLE 82 INDIA: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 119
TABLE 83 INDIA: HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 119
TABLE 84 INDIA: HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 119
9.4.5 AUSTRALIA 120
9.4.5.1 Initiatives to enhance healthcare access and infrastructure to drive market 120
TABLE 85 AUSTRALIA: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 120
TABLE 86 AUSTRALIA: HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 121
TABLE 87 AUSTRALIA: HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 121
9.4.6 THAILAND 121
9.4.6.1 Increasing healthcare expenditure to drive growth 121
TABLE 88 THAILAND: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 122
TABLE 89 THAILAND: HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 122
TABLE 90 THAILAND: HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 123
9.4.7 SINGAPORE 123
9.4.7.1 Increasing demand for health and aged care services to drive market 123
TABLE 91 SINGAPORE: PERCENTAGE OF DEATHS FROM CARDIOVASCULAR DISEASE 124
TABLE 92 SINGAPORE: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 124
TABLE 93 SINGAPORE: HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 94 SINGAPORE: HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 125
9.4.8 INDONESIA 125
9.4.8.1 Rising number of CVD cases to drive growth 125
TABLE 95 INDONESIA: NUMBER OF ELDERLY CITIZENS (THOUSAND) 125
TABLE 96 INDONESIA: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 126
TABLE 97 INDONESIA: HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 126
TABLE 98 INDONESIA: HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 126
9.4.9 REST OF ASIA PACIFIC 127
TABLE 99 REST OF ASIA PACIFIC: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 127
TABLE 100 REST OF ASIA PACIFIC: HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 101 REST OF ASIA PACIFIC: HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 128
9.5 LATIN AMERICA 128
TABLE 102 LATIN AMERICA: HOLTER ECG MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 128
TABLE 103 LATIN AMERICA: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 129
TABLE 104 LATIN AMERICA: HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 129
TABLE 105 LATIN AMERICA: HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 129
9.5.1 RECESSION IMPACT 130
9.5.2 BRAZIL 130
9.5.2.1 Increasing prevalence of CVD to drive growth 130
TABLE 106 BRAZIL: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 130
TABLE 107 BRAZIL: HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 108 BRAZIL: HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 131
9.5.3 REST OF LATIN AMERICA 131
TABLE 109 REST OF LATIN AMERICA: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 132
TABLE 110 REST OF LATIN AMERICA: HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 132
TABLE 111 REST OF LATIN AMERICA: HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 133
9.6 MIDDLE EAST & AFRICA 133
TABLE 112 MIDDLE EAST & AFRICA: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 134
TABLE 113 MIDDLE EAST & AFRICA: HOLTER ECG MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION) 134
TABLE 114 MIDDLE EAST & AFRICA: HOLTER ECG MARKET, BY END USER, 2020–2027 (USD MILLION) 134
9.6.1 RECESSION IMPACT 135
10 COMPETITIVE LANDSCAPE 136
10.1 OVERVIEW 136
10.2 STRATEGIES OF KEY PLAYERS 136
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN HOLTER ECG MARKET 137
TABLE 115 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS 137
10.3 REVENUE SHARE ANALYSIS 138
FIGURE 28 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN HOLTER ECG MARKET 138
10.4 MARKET SHARE ANALYSIS 138
FIGURE 29 HOLTER ECG MARKET SHARE, BY KEY PLAYER (2021) 138
TABLE 116 HOLTER ECG MARKET SHARE: DEGREE OF COMPETITION 139
10.5 COMPETITIVE LEADERSHIP MAPPING 140
10.5.1 LIST OF EVALUATED VENDORS 140
10.5.2 STARS 140
10.5.3 EMERGING LEADERS 140
10.5.4 PERVASIVE PLAYERS 140
10.5.5 PARTICIPANTS 140
FIGURE 30 HOLTER ECG MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021 141
10.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES 142
10.6.1 PROGRESSIVE COMPANIES 142
10.6.2 STARTING BLOCKS 142
10.6.3 RESPONSIVE COMPANIES 142
10.6.4 DYNAMIC COMPANIES 142
FIGURE 31 HOLTER ECG MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2021 143
10.7 COMPETITIVE BENCHMARKING 144
10.7.1 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS 144
FIGURE 32 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS 144
TABLE 117 HOLTER ECG MARKET: REGIONAL FOOTPRINT OF TOP PLAYERS 144
TABLE 118 HOLTER ECG MARKET: PRODUCT FOOTPRINT OF TOP PLAYERS 144
TABLE 119 HOLTER ECG MARKET: DETAILED LIST OF KEY START-UPS/SMES 145

10.8 COMPETITIVE SCENARIO 145
10.8.1 PRODUCT LAUNCHES AND APPROVALS 145
TABLE 120 KEY PRODUCT LAUNCHES AND APPROVALS 145
10.8.2 DEALS 146
TABLE 121 KEY DEALS 146
11 COMPANY PROFILES 147
11.1 KEY PLAYERS 147
(Business Overview, Products Offered, Recent Developments, and MnM View)*
11.1.1 GE HEALTHCARE 147
TABLE 122 GE HEALTHCARE: BUSINESS OVERVIEW 147
FIGURE 33 GE HEALTHCARE: COMPANY SNAPSHOT (2021) 148
11.1.2 KONINKLIJKE PHILIPS N.V. 151
TABLE 123 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 151
FIGURE 34 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2021) 152
11.1.3 NIHON KOHDEN CORPORATION 155
TABLE 124 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW 155
FIGURE 35 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2021) 156
11.1.4 OSI SYSTEMS, INC. 158
TABLE 125 OSI SYSTEMS, INC: BUSINESS OVERVIEW 158
FIGURE 36 OSI SYSTEMS, INC.: COMPANY SNAPSHOT (2021) 159
11.1.5 HILL-ROM HOLDINGS, INC. (BAXTER INTERNATIONAL INC.) 161
TABLE 126 HILL-ROM HOLDINGS, INC.: BUSINESS OVERVIEW 161
FIGURE 37 HILL-ROM HOLDINGS, INC.: COMPANY SNAPSHOT (2021) 162
11.1.6 MINDRAY MEDICAL INTERNATIONAL LIMITED 164
TABLE 127 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW 164
FIGURE 38 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2021) 165
11.1.7 SCHILLER AG 166
TABLE 128 SCHILLER AG: BUSINESS OVERVIEW 166
11.1.8 BITTIUM CORPORATION 167
TABLE 129 BITTIUM CORPORATION: BUSINESS OVERVIEW 167
FIGURE 39 BITTIUM CORPORATION: COMPANY SNAPSHOT (2021) 168
11.1.9 FUKUDA DENSHI CO., LTD. 169
TABLE 130 FUKUDA DENSHI CO., LTD.: BUSINESS OVERVIEW 169
FIGURE 40 FUKUDA DENSHI CO., LTD.: COMPANY SNAPSHOT (2021) 170
11.1.10 BPL MEDICAL TECHNOLOGIES PVT. LTD. 171
TABLE 131 BPL MEDICAL TECHNOLOGIES PVT. LTD.: BUSINESS OVERVIEW 171
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

11.2 OTHER PLAYERS 172
11.2.1 MEDITECH EQUIPMENT CO. LTD. 172
11.2.2 MIDMARK CORPORATION 172
11.2.3 ALIVECOR, INC. 173
11.2.4 VITALCONNECT 173
11.2.5 IRHYTHM TECHNOLOGIES, INC. 174
11.2.6 BORSAM BIOMEDICAL INSTRUMENTS CO., LTD. 174
11.2.7 NASIFF ASSOCIATES, INC. 175
11.2.8 NASAN MEDICAL ELECTRONICS PVT. LTD. 175
11.2.9 VECTRACOR 176
11.2.10 SCOTTCARE CORPORATION 176
11.2.11 BIOMEDICAL INSTRUMENTS CO. LTD. 177
11.2.12 EB NEURO S.P.A. 177
11.2.13 VIATOM TECHNOLOGY CO., LTD. 178
11.2.14 CARDIAC INSIGHT, INC. 178
11.2.15 LIFESIGNALS, INC. 179
12 APPENDIX 180
12.1 DISCUSSION GUIDE 180
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 183
12.3 CUSTOMIZATION OPTIONS 185
12.4 RELATED REPORTS 185
12.5 AUTHOR DETAILS 186

ページTOPに戻る

Table of Contents

Summary

The global Holter ECG market is projected to reach USD 558 million by 2027 from USD 416 million in 2022, at a CAGR of 6.1% during the forecast period. The aging population, rising cardiovascular disease (CVD) prevalence, awareness of the need for early and ongoing diagnosis, and technological developments in wearable devices are all contributing to the expansion of the Holter ECG market.
“The wired Holter ECG monitors segment accounted for the highest market share during the forecast period”
Based on product, the Holter ECG market is segmented into wired Holter ECG monitors, wireless Holter ECG monitors, and software. The wired Holter ECG monitors segment is expected to witness a high market share during the forecast period. Growth in this market is mainly driven by the growing CVD prevalence and the need to minimize the costs associated with its treatment, along with the high accuracy and precision offered by wired Holter ECG devices in the diagnosis of heart activity.
“12-lead Holter monitor accounted for the highest CAGR during the forecast period”
Based on lead type, the Holter ECG market is segmented into patch type 1-lead, 3-lead, 6-lead, 12-lead, and other lead types (such as 4-, 5-, and 7-lead Holter ECG monitors, among others). In 2021, the 12-lead dominated the market, and the 3-lead observed the highest growth rate. The large share of this segment can be attributed to the wide use of 12-lead Holter monitors in various cardiology diagnostic and treatment applications.
“The North America segment accounted for the highest market share during the forecast period”
Based on the region segmentation, the Holter ECG market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East Africa. North America holds the largest share and expects to dominate the Holter ECG market. The growth of this regional market is backed by the increasing prevalence of cardiovascular disease, the growth in the aging population, and the rising demand for remote monitoring.
Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
• By Designation: C-level (27%), Director-level (18%), and Others (55%)
• By Region: North America (51%), Asia- Pacific (18%), Europe (21%), Latin America (6%) and Middle East & Africa(4%)
Prominent companies include GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Nihon Kohden Corporation (Japan), OSI Systems, Inc. (US), Hill-Rom Holdings, Inc. (Baxter International Inc.) (US), Mindray Medical International Limited (China), SCHILLER AG (Switzerland), Bittium Corporation (Finland), Fukuda Denshi Co., Ltd. (Japan), BPL Medical Technologies Pvt. Ltd. (India), Meditech Equipment Co. Ltd. (China), Midmark Corporation (US), AliveCor, Inc. (US), VitalConnect (US), iRhythm Technologies, Inc. (US), Borsam Biomedical Instruments Co., Ltd. (China), Nasiff Associates, Inc. (US), Nasan Medical Electronics Pvt. Ltd. (India), VectraCor (US), ScottCare Corporation (US), Biomedical Instruments Co. Ltd. (China), EB Neuro S.p.A. (Italy), Viatom Technology Co., Ltd. (China), Cardiac Insight, Inc. (US), and LifeSignals, Inc. (US).

Research Coverage
This research report categorizes the Holter ECG market by product, lead type, end user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the Holter ECG market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements, new product & service launches, mergers and acquisitions, and recent developments associated with the Holter ECG market. Competitive analysis of upcoming startups in the Holter ECG market ecosystem is covered in this report.

Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall Holter ECG market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
• Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the Holter ECG market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the Holter ECG market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the Holter ECG market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the Holter ECG market
• Competitive Assessment: In-depth assessment of market ranking, growth strategies, and service offerings of leading players like GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Nihon Kohden Corporation (Japan), OSI Systems, Inc. (US), Hill-Rom Holdings, Inc. (Baxter International Inc.) (US) among others in the Holter ECG market strategies.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

MarketsandMarkets社のMedical Devices分野での最新刊レポート

本レポートと同じKEY WORD（ecg）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療機器）の最新刊レポート

MarketsandMarkets社のMedical Devices分野での最新刊レポート

本レポートと同じKEY WORD（ecg）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?